Catalyst Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21K | Sell |
241
-63
| -21% | -$5.5K | ﹤0.01% | 435 |
|
2025
Q1 | $20.8K | Sell |
304
-729
| -71% | -$49.8K | ﹤0.01% | 407 |
|
2024
Q4 | $80.3K | Buy |
1,033
+726
| +236% | +$56.5K | ﹤0.01% | 327 |
|
2024
Q3 | $20.6K | Sell |
307
-78
| -20% | -$5.23K | ﹤0.01% | 447 |
|
2024
Q2 | $43.7K | Buy |
385
+15
| +4% | +$1.7K | ﹤0.01% | 257 |
|
2024
Q1 | $51.3K | Buy |
370
+6
| +2% | +$832 | ﹤0.01% | 242 |
|
2023
Q4 | $45.2K | Buy |
364
+77
| +27% | +$9.56K | ﹤0.01% | 226 |
|
2023
Q3 | $26.8K | Buy |
287
+74
| +35% | +$6.9K | ﹤0.01% | 293 |
|
2023
Q2 | $27.4K | Sell |
213
-18
| -8% | -$2.31K | ﹤0.01% | 290 |
|
2023
Q1 | $26.8K | Sell |
231
-71
| -24% | -$8.25K | ﹤0.01% | 277 |
|
2022
Q4 | $34.2K | Sell |
302
-11
| -4% | -$1.25K | ﹤0.01% | 267 |
|
2022
Q3 | $25K | Buy |
313
+1
| +0.3% | +$80 | ﹤0.01% | 297 |
|
2022
Q2 | $23K | Buy |
312
+44
| +16% | +$3.24K | ﹤0.01% | 314 |
|
2022
Q1 | $34K | Buy |
268
+52
| +24% | +$6.6K | ﹤0.01% | 340 |
|
2021
Q4 | $29K | Sell |
216
-16
| -7% | -$2.15K | ﹤0.01% | 331 |
|
2021
Q3 | $32K | Sell |
232
-4
| -2% | -$552 | ﹤0.01% | 316 |
|
2021
Q2 | $25K | Buy |
236
+8
| +4% | +$847 | ﹤0.01% | 346 |
|
2021
Q1 | $20K | Sell |
228
-44
| -16% | -$3.86K | ﹤0.01% | 322 |
|
2020
Q4 | $25K | Sell |
272
-75,728
| -100% | -$6.96M | ﹤0.01% | 298 |
|
2020
Q3 | $7.83M | Sell |
76,000
-4,800
| -6% | -$495K | 0.44% | 33 |
|
2020
Q2 | $8.19M | Buy |
80,800
+18,800
| +30% | +$1.91M | 0.42% | 33 |
|
2020
Q1 | $4.17M | Buy |
+62,000
| New | +$4.17M | 0.21% | 66 |
|